• Explore /
  • Poster
  • / A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: a novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC).

A personalized approach using hypoxia resolution to guide curative-intent radiation dose-reduction to 30 Gy: a novel de-escalation paradigm for HPV-associated oropharynx cancers (OPC).

Abstract Poster

Authors

null

Nadeem Riaz

Memorial Sloan Kettering Cancer Center, New York, NY

Nadeem Riaz , Eric Jeffrey Sherman , Nora Katabi , Jonathan Eric Leeman , Daniel S. Higginson , Jay Boyle , Bhuvanesh Singh , Luc G. Morris , Richard J. Wong , C. Jillian Tsai , Karen Schupak , Daphna Y. Gelblum , Sean Matthew McBride , Vaios Hatzoglou , Shrujal S. Baxi , David G. Pfister , Amita Dave , John Humm , Heiko Schöder , Nancy Y. Lee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT00606294

Citation

J Clin Oncol 35, 2017 (suppl; abstr 6076)

DOI

10.1200/JCO.2017.35.15_suppl.6076

Abstract #

6076

Poster Bd #

64

Abstract Disclosures

Similar Posters

First Author: Nancy Y. Lee

First Author: Marshall R. Posner

Poster

2017 ASCO Annual Meeting

Optima: A phase II dose and volume de-escalation trial for high- and low-risk HPV+ oropharynx cancers.

Optima: A phase II dose and volume de-escalation trial for high- and low-risk HPV+ oropharynx cancers.

First Author: James Melotek

First Author: Ari Rosenberg